Current and historical daily PE Ratio for ALKS (
Alkermes PLC
) from 1991 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Alkermes PLC stock (ALKS) PE ratio as of Apr 26 2024 is 11.81.
More Details
Alkermes PLC (ALKS) PE Ratio (TTM) Chart
Alkermes PLC (ALKS) PE Ratio (TTM) Historical Data
View and export this data going back to 1991. Start your Free Trial
Total 1216
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Alkermes PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-26 | 11.8 | 2024-02-22 | 14.0 |
| 2024-04-25 | 11.8 | 2024-02-21 | 14.1 |
| 2024-04-24 | 11.9 | 2024-02-20 | 14.7 |
| 2024-04-23 | 11.7 | 2024-02-16 | 15.6 |
| 2024-04-22 | 11.6 | 2024-02-15 | 15.7 |
| 2024-04-19 | 11.5 | 2024-02-14 | 13.5 |
| 2024-04-18 | 11.5 | 2024-02-13 | 13.2 |
| 2024-04-17 | 11.6 | 2024-02-12 | 13.8 |
| 2024-04-16 | 11.5 | 2024-02-09 | 13.2 |
| 2024-04-15 | 11.6 | 2024-02-08 | 12.9 |
| 2024-04-12 | 11.8 | 2024-02-07 | 12.9 |
| 2024-04-11 | 12.1 | 2024-02-06 | 13.1 |
| 2024-04-10 | 12.6 | 2024-02-05 | 12.8 |
| 2024-04-09 | 12.9 | 2024-02-02 | 12.9 |
| 2024-04-08 | 12.5 | 2024-02-01 | 13.0 |
| 2024-04-05 | 12.6 | 2024-01-31 | 13.1 |
| 2024-04-04 | 12.5 | 2024-01-30 | 13.2 |
| 2024-04-03 | 12.7 | 2024-01-29 | 13.7 |
| 2024-04-02 | 12.9 | 2024-01-26 | 13.4 |
| 2024-04-01 | 13.2 | 2024-01-25 | 13.5 |
| 2024-03-28 | 13.1 | 2024-01-24 | 13.6 |
| 2024-03-27 | 13.2 | 2024-01-23 | 13.8 |
| 2024-03-26 | 12.9 | 2024-01-22 | 13.8 |
| 2024-03-25 | 13.2 | 2024-01-19 | 13.5 |
| 2024-03-22 | 13.2 | 2024-01-18 | 13.4 |
| 2024-03-21 | 13.0 | 2024-01-17 | 13.4 |
| 2024-03-20 | 13.4 | 2024-01-16 | 13.4 |
| 2024-03-19 | 13.4 | 2024-01-12 | 13.6 |
| 2024-03-18 | 13.3 | 2024-01-11 | 13.5 |
| 2024-03-15 | 13.9 | 2024-01-10 | 13.6 |
| 2024-03-14 | 13.9 | 2024-01-09 | 14.0 |
| 2024-03-13 | 13.9 | 2024-01-08 | 14.3 |
| 2024-03-12 | 13.8 | 2024-01-05 | 13.8 |
| 2024-03-11 | 13.8 | 2024-01-04 | 13.8 |
| 2024-03-08 | 14.1 | 2024-01-03 | 13.8 |
| 2024-03-07 | 14.2 | 2024-01-02 | 13.8 |
| 2024-03-06 | 14.0 | 2023-12-29 | 13.4 |
| 2024-03-05 | 14.4 | 2023-12-28 | 13.5 |
| 2024-03-04 | 14.4 | 2023-12-27 | 22.6 |
| 2024-03-01 | 14.6 | 2023-12-26 | 22.5 |
| 2024-02-29 | 14.3 | 2023-12-22 | 22.5 |
| 2024-02-28 | 14.4 | 2023-12-21 | 22.2 |
| 2024-02-27 | 14.3 | 2023-12-20 | 21.9 |
| 2024-02-26 | 14.5 | 2023-12-19 | 22.4 |
| 2024-02-23 | 14.3 | 2023-12-18 | 21.8 |
Alkermes PLC (ALKS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Alkermes PLC
NAICS : 325412
SIC : 2834
ISIN : IE00B56GVS15
Share Class Description:
ALKS: Ordinary SharesDescription
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers